Unveiling Novartis (NVS) Q1 Outlook: Wall Street Estimates for Key Metrics

Evaluate the expected performance of Novartis (NVS) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.